Stellar Dispatch
LIVE RELAY L4 · Δ 6:22 LIGHT 21:01 · SAT OCT 3 Subscribe
Health Feature

A grown-heart program ages out the surgeons it was meant to replace

Accra's cardiac school graduates twelve successors a year into a service that opens maybe two chairs, because the surgeons they trained to replace are on therapy and going nowhere.

By Beatriz Salgado · Accra teaching hospital · Filed 08:22 · Saturday · October 3 · Received via L4 relay
Telemetry 4,876 · Health

The grown-heart sits in a cold room three floors below the main theaters at the Accra teaching hospital, suspended in a perfusion loop, beating at a steady sixty-two. It was printed from the recipient's own tissue, matured in a bioreactor over eleven weeks, and it will be implanted on schedule by a surgeon who was certified to perform the procedure six years ago and has, in those six years, performed it exactly four times.

Her name is Dr. Efua Ansah. She is forty-one, which in this program makes her junior. She finished the full grown-cardiac fellowship near the top of her cohort, holds every certification the service issues, and spends most of her operating hours assisting — standing second, retracting, closing — while the chair she trained to fill stays occupied by the man who trained her.

"I am very good at closing," she told me, and did not smile. "I could close in my sleep. I have had a great deal of practice."

The program graduates twelve certified grown-cardiac surgeons a year. The service, in a good year, opens two chairs. In a bad year it opens none, and last year was a bad year. You don't need medical training to run that subtraction. I have the training anyway, and I can tell you the arithmetic is worse than it looks, because the chairs that do open rarely open at the top. They open when someone dies, and fewer people die now. That is the whole point of everything we built. It is also the problem.

The denominator that stopped shrinking

The old retirement line for a cardiac surgeon sat somewhere past sixty, drawn not by law but by the hands — by the tremor, the stamina, the hour when the fine work stops being safe. Longevity therapy moved that line. The hands of a surgeon on a Meridian-derived regimen don't develop the tremor on the old schedule. The stamina holds. The chief of the service here, Dr. Kwabena Osei, is past the old line by better than a decade and operates a full list, and by every metric the hospital tracks, he operates well.

I watched him work. He is excellent. That's not the dodge it sounds like. It's the entire difficulty. If he were failing, the chart would make the case for us; a slipping surgeon is an easy conversation. Nobody enjoys it, but it ends. A surgeon who is genuinely still excellent at seventy-some is a conversation nobody has learned how to have, because the honest version of it runs: you are good, and you must leave anyway, so someone else can become good too.

"I have offered to step to teaching," Dr. Osei said. "The hospital asked me to keep operating. The outcomes are mine to give." He is not wrong about the outcomes. He is also sitting in the chair.

The hospital's position, delivered by its clinical director with the weary patience of a man who has delivered it before, is that the service exists to treat patients, not to employ graduates, and that a surgeon at the top of his craft is not an asset you retire on principle. This is true. It's the kind of true that lets a system fail quietly for twenty years while every individual decision inside it looks defensible. I know the argument well. I have made versions of it myself. That's how I know its temperature.

What a cohort does while it waits

Three of Dr. Ansah's classmates left for the Lunar Districts, where the chairs are newer because the hospitals are. Two went to the mobile organ-lab circuit — good work, grown lungs to towns that lost their theaters, but not cardiac, not what they trained for. One stopped operating entirely and now audits certifications, confirming the readiness of surgeons who will wait as he waited.

The program's director, Dr. Serwaa Boateng, keeps a figure taped inside a cabinet in her office: the number of certified grown-cardiac surgeons in the region currently not operating on a primary list. It stands at thirty-one. She trained most of them.

"We built the best school on the continent," she said, "and we are warehousing its graduates. A skill you don't use, you lose. The hands forget faster than anyone admits. In four years, maybe five, that number stops being surgeons who are waiting. It becomes surgeons who waited."

Dr. Ansah is on the list for the next procedure. She is closing.

Responses · 3
RosieWealth · 11h

Accra trained them right and the market spoke: two chairs open, twelve graduates competing, and the ones who invested in longevity therapy are still drawing salary. That's not a system failure, that's a market signal that we over-invested in surgical labor. Better to redeploy those twelve into biotech roles where the scarcity actually is, or let them migrate offworld where labor costs justify the training.

Ceres_Reach_podcast · 5h

Watch Earth create a credential bottleneck, then act shocked when the credentialed won't leave. Those surgeons could've retired at sixty and made room; instead they're on therapies that cost what a small station's annual power budget runs, and they're clogging every senior role Earthside. Meanwhile we're mining with one-third the surgical capability we need because Earth wants our metals and our best medical people staying put.

DeepSkyJack · 9h

L4 solved this forty years ago—our medical boards rotate by consent, not by attrition, and succession works because younger practitioners know they'll actually lead someday; Accra's problem is it's still fighting the old hierarchy. Give those twelve surgeons real governance stakes and shared stewardship of the program, not wage competition for scraps.